FIT: Diet in Twin Pregnancy: the Wellness of Mother and Babies.

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Recruiting
CT.gov ID
NCT05773677
Collaborator
(none)
200
1
2
17.7
11.3

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate how variations in maternal nutrition may affect twin pregnancy and in particular:

  • incidence of maternal obstetric complications:

  • gestational diabetes

  • gestational hypertension or preeclampsia

  • intrahepatic cholestasis (ICP)

  • fetal growth, development and birth weight of the babies

Detailed Description

Study design

At the time of recruitment, each patient will perform an initial clinical nutrition examination, during which will be evaluated, on the basis of BMI and specific anthropometric parameters, the necessary nutritional intake.

Patients included in the study will then be classified, on the basis of pre-pregnancy BMI, into 2 classes:

  • normal weight (BMI 18-25)

  • overweight (BMI 25-30) A specific diet will be developed for each patient, which will also take into account any food allergies or intolerances.

Each diet will be then eventually modified and revised throughout the pregnancy, according to the evolution of the same.

Patients will then continue their regular obstetrical examinations at the Obstetrical Day Hospital, every 4 weeks in case of uncomplicated dichorionic twin pregnancy and every 2 weeks in case of uncomplicated monochorionic twin pregnancy.

Once a month, in coincidence with the appointment at the Obstetric Day Hospital, the enrolled patients will be evaluated by the dedicated team of nutritionists.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Case group: prospective Control group: retrospectiveCase group: prospective Control group: retrospective
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
FIT: Food in Twins. Diet in Twin Pregnancy: the Wellness of Mother and Babies.
Actual Study Start Date :
Oct 10, 2022
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Case Group: with diet

Prescription of specific diet in pregnancy

Dietary Supplement: Specific Diet
A specific diet will be developed for each patient, which will also take into account any food allergies or intolerances. Each diet will be then eventually modified and revised throughout the pregnancy, according to the evolution of the same.

No Intervention: Control Group: no diet

Retrospective group with no diet

Outcome Measures

Primary Outcome Measures

  1. incidence of maternal obstetric complications: [From enrollment in the study to delivery]

    gestational diabetes gestational hypertension or preeclampsia -intrahepatic cholestasis (ICP)

Secondary Outcome Measures

  1. fetal growth and birth weight of the babies [From enrollment in the study to delivery]

    estimated fetal weight and actual fetal weight at delivery (expressed in grams)

  2. maternal weight gain [From enrollment in the study to delivery]

    expressed in kilograms

  3. differences in early or late enrollment of patients [From enrollment in the study to delivery]

    advantage of early enrollment in reducing the incidence of the above complications (expressed as percentage)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • dichorionic-diamniotic twin pregnancies

  • monochorionic-diamniotic twin pregrancies

  • monochorionic- monoamniotic twin pregnancies

  • spontaneous onset or by homologous PMA techniques

  • Age between 18 and 40 years

  • Gestational age between 8 weeks+0 days and 25 weeks+6 days

Exclusion Criteria:
  • Pregestational diabetes mellitus (type I and II)

  • Chronic hypertension

  • Previous bariatric surgery

  • Chronic gastrointestinal disease (Celiac disease, Crohn's disease, Ulcerative Rectocolitis)

  • Age less than 18 years or more than 40 years

  • Gestational age less than 8 weeks or more than 26 weeks

  • Fetal structural and/or genetic abnormalities

  • Heterologous PMA

  • Maternal eating disorders

  • Drug and/or alcohol use

  • Multiple pregnancies with more than two babies

Contacts and Locations

Locations

Site City State Country Postal Code
1 FPGemelliIRCCS Roma Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Visconti Daniela, Principal Investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT05773677
Other Study ID Numbers:
  • 5078
First Posted:
Mar 17, 2023
Last Update Posted:
Mar 20, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2023